Balchem R&D chief reports 6,335 directly held shares

The reported holdings span directly and indirectly held common stock, restricted shares with vesting terms, and an employee option exercisable in 2027.

Rhea-AI Filing Summary

BALCHEM CORP SVP and Chief R&D Officer Ren Anthony Gonzalez reported 6,335 directly held common shares and 884 common shares held indirectly through a 401(k) Plan as of September 16, 2026. A footnote to the common-stock entry states that ownership of 6,133 restricted shares vests between 1 and 3 years following the various grant dates and is subject to transfer restrictions. Gonzalez also reported an employee option covering 240 common shares, with a $143.43 exercise price, an exercise date of February 8, 2027, and an expiration date of February 8, 2034.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Gonzalez Ren Anthony

Role SVP and Chief R&D Officer

Type	Security	Shares	Price	Value
holding	Employee Stock Option (right to buy)	--	--	--
holding	Common Stock F1	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Employee Stock Option (right to buy) — 240 contracts (Direct); Common Stock — 6,335 shares (Direct); Common Stock — 884 shares (Indirect, 401(k) Plan)

Footnotes (1)

1. F1. Ownership of 6,133 shares of restricted stock vests in Reporting Person between 1 and 3 years following the various grant dates and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.

Key Figures

Directly held common stock: 6,335 shares Indirectly held common stock: 884 shares Restricted stock: 6,133 shares +4 more

7 metrics

Directly held common stock 6,335 shares Reported as of September 16, 2026

Indirectly held common stock 884 shares Held through a 401(k) Plan; reported as of September 16, 2026

Restricted stock 6,133 shares Vests between 1 and 3 years following the various grant dates

Employee option underlying common shares 240 shares Reported as of September 16, 2026

Exercise price $143.43 per share Employee option

Option exercise date February 8, 2027 Employee option

Option expiration date February 8, 2034 Employee option

Key Terms

Employee Stock Option (right to buy), Restricted Stock Grant Agreement, 401(k) Plan

3 terms

Employee Stock Option (right to buy) financial

"Employee Stock Option (right to buy)"

Restricted Stock Grant Agreement financial

"a Restricted Stock Grant Agreement between the Issuer and the Reporting Person"

401(k) Plan financial

"Common Stock held through a 401(k) Plan"

A 401(k) plan is a workplace retirement account that lets employees set aside part of their pay into a tax-advantaged savings pot, often with employers adding matching contributions — like a workplace piggy bank for future income. It matters to investors because the amount people save and how employers fund these plans influence consumer spending, corporate payroll costs and the flow of money into financial markets, which can affect stock prices and company valuations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What BALCHEM (BCPC) stock holdings did Ren Anthony Gonzalez report?

As of September 16, 2026, Ren Anthony Gonzalez reported 6,335 directly held common shares and 884 common shares held indirectly through a 401(k) Plan.

What are the terms of Ren Anthony Gonzalez's BCPC employee stock option?

The reported option covers 240 common shares at a $143.43 exercise price. Its exercise date is February 8, 2027, and its expiration date is February 8, 2034.

What agreement governs the transfer restrictions on Ren Anthony Gonzalez's BCPC restricted stock?

The restricted stock is subject to transfer restrictions under a Restricted Stock Grant Agreement between BALCHEM CORP and Ren Anthony Gonzalez.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/24/2026 - 04:24 PM Accepted by SEC EDGAR 09/24/2026 - 04:23 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Gonzalez Ren Anthony

(Last) (First) (Middle)

C/O BALCHEM CORPORATION

5 PARAGON DRIVE

(Street)

MONTVALE NEW JERSEY 07645

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
09/16/2026

3. Issuer Name and Ticker or Trading Symbol
BALCHEM CORP [ BALCHEM CO ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP and Chief R&D Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock(1)	6,335	D
Common Stock	884	I	401(k) Plan

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	02/08/2027	02/08/2034	Common Stock	240	$143.43	D

Explanation of Responses:

1. Ownership of 6,133 shares of restricted stock vests in Reporting Person between 1 and 3 years following the various grant dates and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.

Remarks:

Exhibit 24 - Power of Attorney is attached.

	/s/ Travis Larsen, Attorney in Fact for Ren Anthony Gonzalez	09/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)